Amalgamated Bank Vaxxinity, Inc. Transaction History

Amalgamated Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.62 - $0.86 $2,850 - $3,953	-4,597 Reduced 76.18%	1,437 $1,000
Q4 2023 Feb 06, 2024	SELL	$0.7 - $1.31 $299 - $560	-428 Reduced 6.62%	6,034 $5,000
Q2 2023 Aug 11, 2023	BUY	$1.73 - $2.79 $11,179 - $18,028	6,462 New	6,462 $16,000

287K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Market Cap $1.12M
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.